The Net Margin of Newron Pharmaceuticals SpA (NWRN.SW) is 30.83%.
Net Margin measures the percentage of net income derived from total revenue after all expenses. It signals how much actual profit a company retains from its sales.
| Date | Value |
|---|---|
| 2024-12-31 | 30.83% |
| 2023-12-31 | -179.13% |
| 2022-12-31 | -287.05% |
| 2021-12-31 | -258.61% |
| 2020-12-31 | -399.35% |
| 2019-12-31 | -287.11% |
| 2018-12-31 | -373.54% |
| 2017-12-31 | -39.76% |
| 2016-12-31 | -321.66% |
| 2015-12-31 | -1002.90% |